secwatch.observer — SEC 8-K summary
======================================

Issuer:     Spectral AI, Inc. (MDAI)
CIK:        0001833498
Form:       8-K
Filed at:   2026-06-01T20:01:42+00:00
Accession:  0001213900-26-063486
Event type: other_material
Sentiment:  positive
Materiality: 0.85
Item codes: 5.07, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Spectral AI gets FDA clearance for DeepView burn indication; targets first commercial sales by year-end 2026
--------------------------------------------------------------------------------

- FDA De Novo clearance for DeepView System for Burn Indication; commercial distribution authorized in US.
- BARDA awarded $31.7M advanced funding to accelerate DeepView System features.
- All five director nominees elected; shareholders approved auditor and Hudson Bay share issuance.
- First commercial sales expected by Q4 2026 in US (up to 30 devices via BARDA) and international markets.
- Outcome Study planned for Q4 2026 with ~286 patients across 12 sites.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1833498/000121390026063486/0001213900-26-063486-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1833498/000121390026063486/ea0292962-8k_spectral.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-063486

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer